Clyde Glasgow

Nov 25, 2024 | associationofanaesthetists-publications.onlinelibrary.wiley.com | Owen T. Lewis |James Lloyd |Clyde Glasgow |Jenny Ferry

Introduction Regional anaesthesia provides important clinical benefits to patients but is underutilised. A barrier to widespread adoption may be the focus of regional anaesthesia research on novel techniques rather than evaluating and optimising existing approaches. Research priorities in regional anaesthesia identified by anaesthetists have been published, but the views of patients, carers and other healthcare professionals have not been considered previously.

May 3, 2024 | dom-pubs.onlinelibrary.wiley.com | Kaitlin J. Mayne |Glasgow Renal |Clyde Glasgow |Peter Hanlon

1 INTRODUCTION AND SCOPE OF REVIEW Globally, chronic kidney disease (CKD) is thought to affect about 9.5% of the population, or about 850 million people in total.1 In the context of ageing populations and the increasing prevalence of multimorbidity (including among younger people), the prevalence of CKD is set to rise further. By 2040, CKD is expected to be the fifth leading cause of death globally. CKD has a huge and growing economic impact.